Cas 686298-41-9,Phenylalanine, N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-3,4- dimethyl-

686298-41-9

Post Buying Request

Basic information

Product Name: Phenylalanine, N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-3,4- dimethyl-
Synonyms:
CAS NO:686298-41-9
Molecular Formula: C25H30N4O4
Molecular Weight: 450.538
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Phenylalanine, N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-3,4- dimethyl-(CAS DataBase Reference)
NIST Chemistry Reference: Phenylalanine, N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-3,4- dimethyl-(686298-41-9)
EPA Substance Registry System: Phenylalanine, N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-3,4- dimethyl-(686298-41-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 686298-41-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

686298-41-9 Suppliers

Recommended suppliers

686298-41-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 686298-41-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,6,2,9 and 8 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 686298-41:
(8*6)+(7*8)+(6*6)+(5*2)+(4*9)+(3*8)+(2*4)+(1*1)=219
219 % 10 = 9
So 686298-41-9 is a valid CAS Registry Number.

686298-41-9Upstream product

686298-40-8 3-(3,4-dimethyl-phenyl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-carbonyl]-amino}-propionic acid ethylester

686298-41-9Downstream Products

686298-41-9Relevant academic research and scientific papers

SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT

-

Page/Page column 161; 162, (2010/02/06)

The invention relates to CGRP antagonists of general formula (I), in which A, X, Y, Z and R1 to R 3 are as defined in claim 1, the tautomers, diastereomers, enantiomers, hydrates, mixtures, salts, hydrates of the salts, in particular

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 686298-41-9